Benefits
Reduction of aflatoxin-DNA adducts (high-risk populations)
Egner 2001 (PMID 11724948, PNAS) double-blind placebo-controlled RCT in Qidong, China — adults unavoidably exposed to dietary aflatoxin (high liver cancer region) received 100 mg CHL three times daily. Result: 55% reduction (median) in urinary aflatoxin-N7-guanine adduct excretion vs placebo. Adduct is biomarker of carcinogen-DNA damage associated with hepatocellular carcinoma risk. Excellent compliance, no toxicities. The strongest single piece of evidence for chlorophyllin chemoprevention.
Internal deodorizer (FDA-approved OTC)
Sodium copper chlorophyllin is FDA-approved as OTC drug (Derifil, Nullo) for fecal odor reduction in incontinence. Mechanism unclear but established practical effect. Modest evidence beyond product label claims; works for some users but not all. Has been used clinically since 1950s.
Mechanism: complexes with carcinogens in gut
Chlorophyllin forms tight molecular complexes (Kd ~1.4 μM) with aflatoxin B1 and other planar polycyclic carcinogens (heterocyclic amines from cooked meat, polycyclic aromatic hydrocarbons from grilled food/smoke). These complexes are too large to absorb across gut wall, effectively binding carcinogens in lumen and increasing fecal excretion. Validated in human pharmacokinetic studies (Jubert 2017).
Modest oral wound healing and skin support
Older evidence (1950s-60s) suggests chlorophyllin promotes wound healing, particularly for chronic ulcers and pressure sores. Recent reformulations of chlorophyllin in burn dressings and oral mucositis preparations show some clinical benefit. Generally a minor traditional use compared to dedicated wound care interventions.
Potential weight management role (very limited evidence)
Montelius 2014 RCT (Appetite, n=38 women) showed thylakoid (chlorophyll-rich plant membrane) supplementation reduced craving for sweet/savory foods and improved satiety. However, this is thylakoid (a complex chloroplast membrane), not pure chlorophyll. Single small trial. The broader 'chlorophyll for weight loss' claims popular on social media lack rigorous RCT support.
Mechanism of action
Carcinogen complex formation (the dominant chemoprevention mechanism)
Chlorophyllin's planar porphyrin ring forms π-π stacking complexes with planar polycyclic aromatic compounds — including aflatoxin B1, AFB1-8,9-epoxide (the ultimate carcinogenic metabolite), heterocyclic amines (PhIP, IQ from grilled meat), and PAHs (BaP from smoke/grilled food). Complex Kd ~1.4 μM. The complexes are non-absorbable, increasing fecal carcinogen excretion. This is the proven mechanism for the Qidong RCT reduction in AFB-N7-guanine.
Antioxidant activity (modest in vivo)
Chlorophyll and chlorophyllin scavenge various reactive oxygen species and reduce lipid peroxidation in vitro. The copper (in CHL) and magnesium (in native chlorophyll) centers can participate in redox chemistry. Clinical antioxidant relevance is modest — many other dietary antioxidants are more efficient.
Phase II detoxification enzyme induction
Chlorophyllin induces NAD(P)H:quinone oxidoreductase 1 (NQO1) and glutathione-S-transferase activity in vitro and in some animal studies. May contribute to chemoprevention beyond direct carcinogen complexation. Effect modest compared to dedicated Nrf2 activators (sulforaphane, curcumin).
Chlorin e4 ethyl ester metabolite
Egner 2000 (PMID 10995263) identified copper chlorin e4 ethyl ester in serum of Qidong CHL trial participants — confirming systemic absorption of a CHL-derived metabolite. Provides additional evidence that chlorophyllin is bioavailable beyond just luminal binding effects.
Clinical trials
Double-blind, placebo-controlled, randomized clinical trial (Egner PA, Wang JB, Zhu YR, Zhang BC, Wu Y, Zhang QN, Qian GS, Kuang SY, Gange SJ, Jacobson LP, Helzlsouer KJ, Bailey GS, Groopman JD, Kensler TW 2001, PNAS 98(25):14601-14606, doi:10.1073/pnas.251536898, PMID 11724948).
180 adults from Qidong, Jiangsu Province, China — a high-risk region for HBV-related hepatocellular carcinoma where dietary aflatoxin exposure is unavoidable. Randomized to 100 mg sodium copper chlorophyllin (CHL) three times daily or placebo for 12 weeks. Urinary aflatoxin-N7-guanine adducts measured.
Median 55% reduction in urinary excretion of aflatoxin-N7-guanine in CHL group vs placebo (p<0.05). The biomarker is derived from the ultimate carcinogenic metabolite of aflatoxin B1 and is associated with increased risk of hepatocellular carcinoma in prospective epidemiologic studies. Outstanding compliance; no toxicities observed. Concluded CHL is safe and effective agent for individuals unavoidably exposed to aflatoxin. Foundational chemoprevention RCT — among most rigorous evidence supporting any dietary supplement intervention.
Comprehensive review (Egner PA, Muñoz A, Kensler TW 2003, Mutat Res 523-524:209-216, doi:10.1016/s0027-5107(02)00337-8, PMID 12628519).
Review of chlorophyllin chemoprevention literature including the Qidong human trial, animal models, and mechanistic studies.
Established CHL as safe and effective intervention for populations unavoidably exposed to aflatoxin. Mechanism centered on carcinogen molecular complex formation blocking bioavailability. Authors noted that combination with hepatitis B virus reduction efforts is critical for liver cancer prevention. The most authoritative review of chlorophyllin chemoprevention from the lead investigator team.
Unblinded crossover pharmacokinetic study (Jubert C, Mata J, Bench G, Dashwood R, Pereira C, Tracewell W, Turteltaub K, Williams D, Bailey G 2017, Cancer Prev Res 2(12):1015-1022, doi:10.1158/1940-6207.CAPR-09-0099, PMID 19952359).
4 healthy human volunteers receiving Institutional Review Board-approved dose of 14C-aflatoxin B1 (30 ng, 5 nCi) in capsule with or without natural chlorophyll (Chla) or chlorophyllin (CHL) cotreatment. Blood and cumulative urine over 72 hours. 14C-AFB1 measured by accelerator mass spectrometry.
Both Chla and CHL reduced AFB1 absorption and circulating levels — confirming bioavailability-blocking mechanism extends to NATURAL chlorophyll (from food sources) and not just water-soluble CHL salt. Results extended Qidong RCT findings to natural dietary chlorophyll. Important rationale for green leafy vegetable consumption in aflatoxin-exposed populations.
About this ingredient
Chlorophyll is the green pigment of all photosynthetic plants and algae — the central molecule of photosynthesis. Two main forms in plants: chlorophyll a (the primary photosynthetic pigment, with methyl group at C7) and chlorophyll b (with formyl/aldehyde group at C7, accessory pigment). Both have a porphyrin ring with magnesium center coordinated to four pyrrole nitrogens, plus a hydrocarbon phytol tail (~20 carbons) making them lipophilic.
PHARMACEUTICAL/SUPPLEMENT FORM is sodium copper chlorophyllin (CHL): water-soluble salt produced by saponification of natural chlorophyll (removing the phytol tail) and substituting copper for magnesium in the porphyrin center. CHL is more stable and water-soluble than native chlorophyll, making it suitable for supplements, food coloring (FD&C colorants), and oral medications. FDA-approved OTC drug for fecal/urine deodorization in incontinence (Derifil®, Nullo®).
FOOD SOURCES: spinach (~0.5 mg/g), parsley (~3 mg/g), arugula (~2 mg/g), broccoli (~0.4 mg/g), wheatgrass concentrate (~5 mg/g). Most commercial 'liquid chlorophyll' supplements actually contain chlorophyllin (more shelf-stable) plus glycerin or water. EVIDENCE: 3/5 reflects: (1) STRONG RCT evidence in aflatoxin-exposed Chinese cohort (Egner 2001 PMID 11724948, n=180, 55% reduction in carcinogen-DNA adducts), (2) confirmed mechanism via carcinogen molecular complexation (Breinholt 1995 PMID 7805041), (3) FDA-approved OTC use for fecal odor (Derifil), (4) extended evidence to natural dietary chlorophyll (Jubert 2017 PMID 19952359), (5) extensive preclinical chemoprevention literature in trout, rats, mice.
Limited evidence for the popular 'detox', 'energy', 'weight loss', 'skin clearing' claims that dominate consumer marketing — these claims largely lack rigorous trial support. SAFETY: Excellent — FDA GRAS, decades of safe use as food coloring and pharmaceutical. Best positioned as: (a) supplement adjunct in populations with unavoidable aflatoxin exposure (high-risk regions, occupational/dietary), (b) FDA-approved OTC fecal/urine deodorizer in incontinence, (c) general dietary support via green leafy vegetable consumption (whole-food sources), (d) NOT a 'cleanse' or weight loss intervention based on current evidence.
The Qidong trial is one of the most rigorous chemoprevention studies ever conducted, but its specific population/exposure context limits direct generalization to North American/European supplement users with low aflatoxin exposure.